Nerlynx
My Prescription
Payment
Select pharmacy
$19,342.52
Print or send this coupon to your phone
AlbertsonsPowered byAbout Nerlynx
Drug Details
Neratinib, marketed as Nerlynx, is an oral medication used to treat HER2-positive breast cancer. It is classified as a kinase inhibitor, which functions by blocking the activity of proteins HER2 and EGFR that contribute to the growth of cancer cells. This medication is particularly used by patients who have previously undergone other breast cancer treatments. Depending on the cancer stage, Nerlynx can be taken alone or in combination with another anticancer drug. It is generally administered once daily. However, patients should be aware that diarrhea is a common side effect. Always consult with a healthcare professional before starting any new medication to ensure it is appropriate for your condition.
Price history for Nerlynx
133 Tablets, 40MG
Average retail price for Nerlynx
Average SaveHealth price for Nerlynx
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Nerlynx dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 40MG | 133 Tablets | $19,342.52 | $145.43 |
| 40MG | 180 Tablets | $26,175.02 | $145.42 |
Nerlynx FAQs
Nerlynx is used as an extended adjuvant treatment for adult patients with early-stage HER2-positive breast cancer, following adjuvant trastuzumab-based therapy. It helps to reduce the risk of cancer recurrence.
Neratinib is not classified as a traditional chemotherapy drug. It is a type of targeted therapy known as a tyrosine kinase inhibitor, specifically used to treat certain types of breast cancer by targeting specific proteins involved in cancer cell growth.
Diarrhea associated with Nerlynx typically begins within the first few days to weeks of starting treatment. It is important for patients to follow their healthcare provider's instructions on managing this side effect, which may include taking antidiarrheal medications as a preventive measure.
Neratinib has shown a success rate in extending disease-free survival in patients with early-stage HER2-positive breast cancer. In clinical trials, it demonstrated a significant reduction in the risk of recurrence or death when used as an extended adjuvant therapy following trastuzumab-based treatment. The exact success rate can vary based on individual patient factors and specific study results, but it has been shown to improve outcomes in this patient population.
Neratinib causes diarrhea primarily because it affects the gastrointestinal tract. As a tyrosine kinase inhibitor, neratinib targets specific proteins involved in cell growth and division, including those in the lining of the intestines. This can disrupt normal cellular processes and lead to increased fluid secretion and motility in the intestines, resulting in diarrhea. This side effect is common with neratinib and is often managed with prophylactic antidiarrheal medications.